{"id":33887,"date":"2024-10-29T13:35:23","date_gmt":"2024-10-29T05:35:23","guid":{"rendered":"https:\/\/umedic.com.my\/Stagging2025\/?p=33887"},"modified":"2024-10-29T13:35:23","modified_gmt":"2024-10-29T05:35:23","slug":"the-edge-15-october-2024","status":"publish","type":"post","link":"https:\/\/umedic.com.my\/Stagging2025\/the-edge-15-october-2024\/","title":{"rendered":"The Edge | 15 October 2024"},"content":{"rendered":"
\n
\n
 <\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
PETALING JAYA: Earnings of healthcare companies in the second half of 2024 (2H24) are likely to come in as strong as posted in 1H24.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

Affin Hwang Investment Bank Research said healthcare companies under its coverage registered strong second quarter (2Q24) earnings, which were primarily driven by the hospital operators.<\/p>\n

\u201cWe view the recent results positively, as an indication of the sector\u2019s resiliency in earnings delivery and see limited risks in our earnings growth estimates.<\/p>\n

\u201cWe expect 2H24 to see similar strength (if not more) when compared to 1H24 as there is a lesser seasonality impact from festivities in the latter,\u201d said the research firm.<\/p>\n

According to Affin Hwang, the hospital market in Malaysia is likely to grow at an annual growth rate of 5.95% from 2024 to 2029.<\/p>\n

It said both IHH Healthcare Bhd<\/a> and KPJ Healthcare Bhd<\/a> are well on track to exceed such expectations.<\/p>\n

\u201cWe have penciled in strong earnings growth for hospital operators in financial year 2024 (FY24) at 21% to 29%, which we believe is achievable despite the recent foreign exchange (forex) movements.\u201d<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n

\u2013 The Edge \u2013<\/p>\n<\/div>\n<\/div>\n

\n
\n
theedgemalaysia.com<\/a><\/div>\n<\/div>\n

 <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

  PETALING JAYA: Earnings of healthcare companies in the second half of 2024 (2H24) are likely to come in as strong as posted in 1H24. Affin Hwang Investment Bank Research said healthcare companies under its coverage registered strong second quarter (2Q24) earnings, which were primarily driven by the hospital operators. \u201cWe view the recent results […]<\/p>\n","protected":false},"author":130,"featured_media":28859,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"

\r\n
\r\n
\r\n
\r\n
\r\n

UMediC Group Berhad (KLSE:UMC<\/a>) Second Quarter 2023 Results<\/h2>\r\n

Key Financial Results<\/h3>\r\n